A study has uncovered that iron orchestrates the activation of two damaging cell death pathways—ferroptosis and ...
Researchers at Karolinska Institutet have identified a new mechanism that may improve the treatment of ischemic stroke. The ...
According to Roche subsidiary Genentech, which announced the label expansion on Monday, TNKase is the first new drug for ...
News Medical on MSN1d
Research identifies iron as crucial driver of stroke-related cell death processesIschemic stroke continues to rank among the top causes of death and long-term disability globally. While advances in acute treatments like clot retrieval and thrombolysis have improved outcomes, the ...
Roche said it has removed its thrombolytic drug tenecteplase from phase 3 for for acute ischaemic stroke, along with several earlier-stage projects. The fibrin-specific plasminogen activator ...
DiaMedica Therapeutics Inc. (Nasdaq: DMAC), a clinical-stage biopharmaceutical company focused on developing novel treatments for severe ischemic diseases, today announced the peer-reviewed ...
Among stroke survivors, the risk of developing dementia after stroke is significantly high, highlighting the need for targeted prevention strategies.
A pivotal study has uncovered that iron orchestrates the activation of two damaging cell death pathways—ferroptosis and ...
Results that may be inaccessible to you are currently showing.
Hide inaccessible results
Feedback